Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.52 USD | +1.00% | +7.51% | -27.67% |
06-17 | Truist Securities Initiates Legend Biotech With Buy Rating, $88 Price Target | MT |
06-03 | Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses | MT |